首页> 美国卫生研究院文献>Haematologica >No correlation of intensity of phlebotomy regimen with risk of thrombosis in polycythemia vera: evidence from European Collaboration on Low-Dose Aspirin in Polycythemia Vera and Cytoreductive Therapy in Polycythemia Vera clinical trials

【2h】

No correlation of intensity of phlebotomy regimen with risk of thrombosis in polycythemia vera: evidence from European Collaboration on Low-Dose Aspirin in Polycythemia Vera and Cytoreductive Therapy in Polycythemia Vera clinical trials

机译：真性红细胞增多症的放血方案强度与血栓形成风险之间没有相关性：欧洲合作研究关于低剂量阿司匹林和真性红细胞增多症的临床研究的证据

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

期刊名称 Haematologica
作者
Tiziano Barbui; Alessandra Carobbio; Arianna Ghirardi; Arianna Masciulli; Alessandro Rambaldi; Alessandro M. Vannucchi;
展开▼
作者单位

展开▼
年(卷),期 2017(102),6
年度 2017
页码 e219–e221
总页数 3
原文格式 PDF
正文语种
中图分类血液学检验;
关键词
入库时间 2022-08-17 12:08:54

相似文献

外文文献
中文文献
专利

1. Risk stratification, staging, and treatment of patients with polycythemia vera: Italian and European collaboration on low-dose aspirin in polycythemia data. [J] . Finazzi G Seminars in Thrombosis and Hemostasis . 2006,第3期

机译：真性红细胞增多症患者的风险分层，分期和治疗：在红细胞增多症数据中，意大利和欧洲在低剂量阿司匹林方面的合作。
2. Disruption of the ASXL1 gene is frequent in primary, post-essential thrombocytosis and post-polycythemia vera myelofibrosis, but not essential thrombocytosis or polycythemia vera: analysis of molecular genetics and clinical phenotypes | Haematologica [J] . Brady L. Stein, Donna M. Williams, Christine O’Keefe, Haematologica . 2011,第10期

机译：ASXL1基因的破坏在原发性，实质性血小板增多症和真性红细胞增多症后骨髓纤维化中很常见，但不是必需的血小板增多症或真性红细胞增多症：分子遗传学和临床表型分析血液学
3. The CYTO-PV: A Large-Scale Trial Testing the Intensity of CYTOreductive Therapy to Prevent Cardiovascular Events in Patients with Polycythemia Vera [J] . RobertoMarchioli, GuidoFinazzi, GiorginaSpecchia, Thrombosis . 2011,第6期

机译：CYTO-PV：大规模试验，测试了CYTO还原疗法的强度，以预防真性红细胞增多症患者的心血管事件
4. Truncation of CXCL12, Stromal Cell Derived Factor-1, by Proteolytic Enzymes in Bone Marrow from Patients with Polycythemia Vera [C] . Sool Yeon Cho, Mingjiang Xu, John Roboz, American Society for Mass Spectrometry Conference on Mass Spectrometry and Allied Topics . 2010

机译：来自多胆症Vera患者的骨髓中的蛋白水解酶截短CXCL12，基质细胞衍生因子-1
5. Persistent Leukocytosis in Polycythemia Vera Is Associated With Disease Evolution but Not Thrombosis [D] . Ronner, Lukas. 2020

机译：持续白细胞增多在多胆症Vera中与疾病演化有关，但不是血栓形成
6. The CYTO-PV: A Large-Scale Trial Testing the Intensity of CYTOreductive Therapy to Prevent Cardiovascular Events in Patients with Polycythemia Vera [O] . Roberto Marchioli, Guido Finazzi, Giorgina Specchia, 2011

机译：CYTO-PV：大规模试验测试了CYTO还原疗法的强度以预防真性红细胞增多症患者的心血管事件
7. No correlation of intensity of phlebotomy regimen with risk of thrombosis in polycythemia vera: evidence from European Collaboration on Low-Dose Aspirin in Polycythemia Vera and Cytoreductive Therapy in Polycythemia Vera clinical trials [O] . Tiziano Barbui, Alessandra Carobbio, Arianna Ghirardi, 2017

机译：没有与多胆症Vera血栓形成血栓形成血栓形成风险的相关性的相关性：来自欧洲对多胆症Vera的低剂量阿司匹林的证据和多胆症Vera临床试验中的细胞血症治疗

No correlation of intensity of phlebotomy regimen with risk of thrombosis in polycythemia vera: evidence from European Collaboration on Low-Dose Aspirin in Polycythemia Vera and Cytoreductive Therapy in Polycythemia Vera clinical trials

著录项

相似文献

相关主题

期刊订阅